8 Reference

BIBLIOGRAPHY
8. BIBLIOGRAPHY
1. Mason c, Nelson s. pulmonary host defenses: clin chest med 1996:20:475-488.
2. Welsh D, Mason C. Host defense in respiratory infections: med clin north am 2001:85:1329-
1347.
3. Andrews J, Nadjm B, Gant V, Shetty N. Community acquired pneumonia: Curr opln pulm
med 2003:9:175-180.
4. Bartlett JG, Dowell SF, Mandell LA. Practice guidelines of the management of community
acquired pneumonia in adults: Clinn Infect Dis 2000:31:347-382.
5. Torres A, Petermans W, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in

adults in Europe: a literature review. Thorax first published as 10.1136/ thoraxjnl 2013;68:1057-
1065.
6. Yende S, Kong L, Weissfeld A, Kellum J, PINKSY MR, Inflammatory markers prior to

hospital discharge predict subsequent mortality after community-acquired pneumonia
2006;3:A274.
7. Kumar S, Agrwal D, Santra S, Das P, Dehury T. Prescribing patter of antibiotics in

community-acquired pneumonia in a teaching hospital of southeast Asia. http;//www.jhrr.org
2015;2:86-90.
8. Sokkary R H, Ramadan R A, Embarak S, Elantouny G N. Community-acquired pneumonia

among adult patients at an Egyptian university hospital. Dove press open access to scientific and
medical research 2018;11:2141-2150.
9. Nelson S, Mason CM, Kolls T. Summer WR: Pathophysiology of pneumonia. Clin Chest Med
1995;16:1-123.
10. Schauner S. Community-Acquired Pneumonia in children: A look at the IDSA guidelines.

Journal of Family Practice 2013;62:9.
Department of pharmacy practice, SHCP/SVIMS – SPMC (W)/Tirupati. Page 42

BIBLIOGRAPHY
11. Collins S, Vickers A, Ladhani SN, Flynn S, Platt S, Ramsay ME. Clinical and molecular
epidemiology of childhood invasive nontypeable Haemophilus influenza disease in England and
Wales. Pediatr Infect Dis J 2016;35(3):e76-84.
12. Kuhnert P, Christensen H. Pasteurellaceae: Biology, Genomics and Molecular Aspects.

Caister Academic Press 2008;ISBN 978-1:34-9.
13. Rudan I, O’Brien KL, Nair H, Theodoratou E, Qazi S. Child Health Epidemiology Reference
Group Lancet 2012;380:2095-128.
14. Taylor-Robinson D. Infections due to species of mycoplasma and ureaplasma. An update.

Clin Infections 1996;23:671.
15. Kumar S, Saigal SR, Sethi GR. Detection of IgM and IgG antibodies. Indian J pathol
Microbial 2011;54:782-785.
16. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Clin Microbial Rev 1995;8(4):451-461.
17. Marriae TJ. Community-acquired pneumonia. Clin Infect Dis 1994;18:501-515.
18. Ewig S, Torres A. Severe Community-Acquired Pneumonia, Clin Chest Med 1999;20:575-
587.
19. Ricketts KD, Joseph CA. Legionnaires disease in Europe 2005;10:256.
20. Brown JS. Geography and Aetiology of Community-Acquired Pneumonia. Respirology

2009;14(8):1068-1071.
21. Chickering HT, Park JH. Staphylococcus aureus pneumonia. JAMA 1919;72:617-626.
22. Ede S, Davis GM, Holmes FH. Staphylococcic pneumonia. JAMA 1959;170:638-643.
23. M. Nawal L, Eric Henley, Linda F. Diagnosis and treatment of community-acquired

pneumonia. Am Fam Physician 2006;1;73(3):442-450.
24. The Australian immunization handbook. 7th ed. Canberra: National Health and
Medical Research Council, 2000.

BIBLIOGRAPHY
25. Blair SG. Preventing and Treating Community-Acquired Pneumonia: A Focus on Men. Us
Pharm 2018;43(8):21-25.
26. Kobayashi M, Bennett NM, Gierke R. Intervals between PCV13 and PPSV23 Vaccines.
Recommendations of the advisory committee on immunization practices. MMWR Morb Mortal
Wkly Rep 2015;64(34):944-947.
27. Dheeraj G, Ritesh A, Ashutosh NA, Navneet S, Narayana M. For the pneumonia guidelines
working group. Lung India 2012;29:S27-S62.
28. Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with
antibiotics active against atypical pathogens in non-severe community acquired pneumonia.
Meta-analysis. Br Med J 2005;330:456.
29. Pertel PE, Bernardo P, Fogarty C, Matthews P, Northland R, Benvenuto M. Effects of prior
effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community
acquired pneumonia. Clin Infect Dis 2008;46:1142-51.
30. Bjerre LM, Verheij TJ, Kochen MM. Antibiotics for community acquired pneumonia in adult
outpatients. Cochrane Database Syst Rev 2009;9:31.
31. Shipra J, Prerna U. A systematic review of prescription pattern monitoring studies and their
effectiveness in promoting rational use of medicines. Prespect Clin Res 2015;6(2):86-90.
32. Gereltuya D, Delia H, Richard P, Bruce S. An evaluation of prescribing practices for

community-acquired pneumonia in Mongolia. Dorj BMC Health Services Research
2013;13:379.
33. Zhang SK, Guo YD, Bloom G. Drug prescribing in rural health facilities in China.
Implications for service quality and cost. Trop Doct 1998;28(1):42-48.
34. Sankar R P, Partha P, Shenoy K N, Easow M J, Brahmadathan N K. Prescribing patterns of

antibiotics and sensitivity patterns of common microorganisms in the internal medicine ward of
teaching hospital in western Nepal: a prospective study. Annals of clinical microbiology and
Antimicrobials 2003;2:1-7.

BIBLIOGRAPHY
35. INRUD: International Network for the Rational Use of Drugs.1989; Available from
http://www.inrudorg/About-INRUD/index.cfm.
36. Woodhead M, Blasi F, Ewig S, Huchon G, Leven M, Ortqvist A. Guidelines for the
management of adult lower respiratory tract infections. Eur Respir J 2005;26(6):1138-80.
37. Niedeman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD. Guidelines
for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med
2001;163(7):1730-1754.

8 Reference

Uploaded by

Copyright:

Available Formats

8 Reference

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

8 Reference

Uploaded by

Copyright:

Available Formats

BIBLIOGRAPHY

1. Mason c, Nelson s. pulmonary host defenses: clin chest med 1996:20:475-488.

5. Torres A, Petermans W, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in

6. Yende S, Kong L, Weissfeld A, Kellum J, PINKSY MR, Inflammatory markers prior to

7. Kumar S, Agrwal D, Santra S, Das P, Dehury T. Prescribing patter of antibiotics in

8. Sokkary R H, Ramadan R A, Embarak S, Elantouny G N. Community-acquired pneumonia

10. Schauner S. Community-Acquired Pneumonia in children: A look at the IDSA guidelines.

Department of pharmacy practice, SHCP/SVIMS – SPMC (W)/Tirupati. Page 42

12. Kuhnert P, Christensen H. Pasteurellaceae: Biology, Genomics and Molecular Aspects.

14. Taylor-Robinson D. Infections due to species of mycoplasma and ureaplasma. An update.

17. Marriae TJ. Community-acquired pneumonia. Clin Infect Dis 1994;18:501-515.

19. Ricketts KD, Joseph CA. Legionnaires disease in Europe 2005;10:256.

20. Brown JS. Geography and Aetiology of Community-Acquired Pneumonia. Respirology

23. M. Nawal L, Eric Henley, Linda F. Diagnosis and treatment of community-acquired

Medical Research Council, 2000.

Department of pharmacy practice, SHCP/SVIMS – SPMC (W)/Tirupati. Page 43

32. Gereltuya D, Delia H, Richard P, Bruce S. An evaluation of prescribing practices for

34. Sankar R P, Partha P, Shenoy K N, Easow M J, Brahmadathan N K. Prescribing patterns of

Department of pharmacy practice, SHCP/SVIMS – SPMC (W)/Tirupati. Page 44

Department of pharmacy practice, SHCP/SVIMS – SPMC (W)/Tirupati. Page 45

You might also like